UPDATE 3-Bowing to pressure, U.S. FDA approves Sarepta?s Duchenne drug
 

UPDATE 3-Bowing to pressure, U.S. FDA approves Sarepta?s Duchenne drug
Sept 19 (Reuters) - Bowing to pressure from patientadvocates, the U.S. Food and Drug Administration on Mondayapproved a treatment for Duchenne muscular dystrophy even thoughan outside panel of...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...QQ:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...QQ:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/AC0OEBPOrjc